RxNorm Release Notes - February 2, 2026
Sources
The following sources have been updated since the previous RxNorm release:
| Source Name | SAB | Version |
|---|---|---|
| DrugBank | DRUGBANK | DRUGBANK5.0_2026_01_02 |
| Gold Standard Drug Database | GS | GS_2026_01_07 |
| Multum MediSource Lexicon | MMSL | MMSL_2026_01_01 |
| Micromedex RED BOOK | MMX | MMX_2026_01_02 |
| Metathesaurus FDA Structured Product Labels | MTHSPL | MTHSPL_2026_01_24 |
| FDB MedKnowledge (formerly NDDF Plus) | NDDF | NDDF_2026_01_07 |
| RxNorm Vocabulary | RXNORM | RXNORM_20AA_260202F |
| USP Compendial Nomenclature | USP | USP_2026_01_12 |
| Veterans Health Administration National Drug File | VANDF | VANDF_2025_12_31 |
The following sources have not been updated since the previous RxNorm release:
| Source Name | SAB | Version |
|---|---|---|
| Anatomical Therapeutic Chemical Classification System | ATC | ATC_2025_02_10 |
| Vaccines Administered | CVX | CVX_2025_11_26 |
| Metathesaurus CMS Formulary Reference File | MTHCMSFRF | MTHCMSFRF_2020 |
| US Edition of SNOMED CT | SNOMEDCT_US | SNOMEDCT_US_2025_07_31 |
RxNorm Data Changes
New Qualitative Distinction: Niacinamide
We have added a new Qualitative Distinction (Niacinamide) to differentiate insulin analogs Fiasp and NovoLog. Fiasp is the faster acting of the two.
Previously, all Fiasp and NovoLog products shared three SCDs:
- 3 ML insulin aspart, human 100 UNT/ML Cartridge
- 3 ML insulin aspart, human 100 UNT/ML Pen Injector
- insulin aspart, human 100 UNT/ML Injectable Solution
The new QD is applied to SCDs and SBDs for Fiasp, but existing RXCUIs have been retained. SCDs and SBDs for other insulin products without niacinamide are unchanged.
Examples:
| RXCUI | TTY | STR |
|---|---|---|
| 2205454 | SBD | Niacinamide 3 ML insulin aspart, human 100 UNT/ML Cartridge [Fiasp] |
| 2730170 | SCD | Niacinamide 3 ML insulin aspart, human 100 UNT/ML Cartridge |
| 1986356 | SBD | Niacinamide 3 ML insulin aspart, human 100 UNT/ML Pen Injector [Fiasp] |
| 2730172 | SCD | Niacinamide 3 ML insulin aspart, human 100 UNT/ML Pen Injector |
| 1986354 | SBD | Niacinamide insulin aspart, human 100 UNT/ML Injectable Solution [Fiasp] |
| 2730174 | SCD | Niacinamide insulin aspart, human 100 UNT/ML Injectable Solution |
Learn more about Qualitative Distinctions in RxNorm.
Data Counts
| Term Type or Attribute | Number |
|---|---|
| Active RXNORM GPCKs | 646 |
| Active RXNORM BPCKs | 745 |
| Active RXNORM SCDs | 17595 |
| Active RXNORM SBDs | 9766 |
| Active RXNORM MINs | 3826 |
| Active RXNORM INs | 14616 |
| Active RXNORM PINs | 3624 |
| Active RXNORM BNs | 5163 |
| Active RXNORM DFs | 126 |
| Obsolete RXNORM GPCKs | 264 |
| Obsolete RXNORM BPCKs | 254 |
| Obsolete RXNORM SCDs | 20040 |
| Obsolete RXNORM SBDs | 12275 |
| Obsolete RXNORM MINs | 0 |
| Obsolete RXNORM INs | 0 |
| Obsolete RXNORM PINs | 0 |
| Obsolete RXNORM BNs | 6658 |
| Obsolete RXNORM DFs | 65 |
| Editor-suppressed RXNORM SCDs | 2170 |
| Editor-suppressed RXNORM SBDs | 1802 |
| SAB=RXNORM NDCs | 253875 |
| Distinct SAB=RXNORM NDCs | 253875 |
Last Reviewed: February 2, 2026